Anthea C Peters (Anthea Peters)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

Current oncology (Toronto, Ont.)

Leukemia & lymphoma

Clinical transplantation

Cells

University of Alberta (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Alberta Sep 01 2000 - Mar 01 2003

Canada

MSC

Publications

Colin Stewart, Carolyn Owen, Mona Shafey, Sarah Perry, Russell Sterrett, Anthea C Peters, Peter R Duggan, Neil Chua, Douglas Stewart, Robert Puckrin
Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era. Bone marrow transplantation (2024)
Madhumita S Manivannan, Xiaoyan Yang, Nirav Patel, Anthea C Peters, James B Johnston, Spencer B Gibson
Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy. Cells 13 (12) (2024)
Madhumita S Manivannan, Xiaoyan Yang, Nirav Patel, Anthea C Peters, James B Johnston, Spencer B Gibson
Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy. Cells 13 (12) (2024)
Madhumita S Manivannan, Xiaoyan Yang, Nirav Patel, Anthea C Peters, James B Johnston, Spencer B Gibson
Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy. Cells 13 (12) (2024)
Anthea C Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica
Management of Marginal Zone Lymphoma: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (2) (2023)
Robert Puckrin, Anthea C Peters
Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical transplantation 37 (2) (2023)
Anthea C Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica
Management of Marginal Zone Lymphoma: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (2) (2023)
Robert Puckrin, Anthea C Peters
Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical transplantation 37 (2) (2023)
Anthea C Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica
Management of Marginal Zone Lymphoma: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (2) (2023)
Anthea C Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica
Management of Marginal Zone Lymphoma: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (2) (2023)
Robert Puckrin, Anthea C Peters
Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical transplantation 37 (2) (2023)
Anthea C Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica
Management of Marginal Zone Lymphoma: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (2) (2023)
Robert Puckrin, Anthea C Peters
Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical transplantation (2023)
Anthea C Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica
Management of Marginal Zone Lymphoma: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (2) (2023)
Grzegorz S Nowakowski, Dok Hyun Yoon, Anthea C Peters, Patrizia Mondello, Erel Joffe, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, Kibum Kim, Pier Luigi Zinzani, Judith Trotman, Dan Huang, Eva E Waltl, Mark Winderlich, Nuwan C Kurukulasuriya, Sumeet Ambarkhane, Georg Hess, Gilles Andre Salles
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Abdulraheem Alshareef, Anthea C Peters, Pascal Gélébart, Will Chen, Raymond Lai
Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma. International journal of molecular sciences 22 (2) (2021)
Yung-Hsing Huang, Meaad Almowaled, Jing Li, Christopher Venner, Irwindeep Sandhu, Anthea C Peters, Afsaneh Lavasanifar, Raymond Lai
Three-Dimensional Reconstructed Bone Marrow Matrix Culture Improves the Viability of Primary Myeloma Cells In-Vitro via a STAT3-Dependent Mechanism. Current issues in molecular biology 43 (1) (2021)
Ryan J Stubbins, Curtis Mabilangan, Marta Rojas-Vasquez, Raymond L Lai, James Zhu, Jutta P Preiksaitis, Anthea C Peters
Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes. Leukemia & lymphoma 61 (14) (2020)
Sarit Assouline, Lilian Amrein, Raquel Aloyz, Versha Banerji, Stephen Caplan, Carolyn Owen, Wanda Hasegawa, Sue Robinson, Sudeep Shivakumar, Anca Prica, Anthea C Peters, Linda Hagerman, Laura Rodriguez, Tanya Skamene, Lawrence Panasci, Bingshu E Chen, Annette E Hay
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia. Leukemia & lymphoma 61 (7) (2020)
Jiajia Liu, Douglas A Stewart, Amelie Fontaine, Anthea C Peters, Isabelle Fleury, Luigina Mollica, Anca Prica, Rena Buckstein, Laurie Sehn, Aixiang Jiang, John Kuruvilla, Diego R Villa
Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy. Leukemia & lymphoma 61 (10) (2020)
Mita Manna, Richard Lee-Ying, Gwynivere A Davies, Colin Stewart, Danielle H Oh, Anthea C Peters, Douglas A Stewart
Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world. Leukemia & lymphoma 60 (1) (2018)
Ryan J Stubbins, Nassiba Alami Laroussi, Anthea C Peters, Simon Urschel, Frank Dicke, Raymond L Lai, James Zhu, Curtis Mabilangan, Jutta K Preiksaitis
Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society 21 (1) (2018)

Anthea C Peters.css-eqlu8i{font-size:small;padding-left:4px;} (Anthea Peters)

Publication Activity (10 Years)

Top Topics

Top Venues

Anthea C Peters (Anthea Peters)